FDA NDC Directory · JSON-LD · Markdown

CYCLOSET

NDC 73515-123 · HUMAN PRESCRIPTION DRUG · TABLET

Generic namebromocriptine mesylate
Labeler / ManufacturerAvvisto Therapeutics LLC
Marketing categoryNew Drug Application (innovator) · App NDA020866
Dosage form / routeTABLET · ORAL
Active ingredientsBROMOCRIPTINE MESYLATE (.8 mg/1)
Marketing started20240523
Package count2

External sources

Source: openFDA. Public-domain (CC0).